ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1064

Trends In Hospitalizations Due To Organ Damage In Patients With Systemic Lupus Erythematosus In Canada, 2006-2010

Amyn Sayani1, Neerav Monga2, Marni Freeman2 and Jorge Alfonso Ross Terres3, 1Medical Affairs, GlaxoSmithKline, Mississauga, ON, Canada, 2Health Economics and Outcomes Research, Medical Division, GlaxoSmithKline, Inc., Mississauga, ON, Canada, 3Medical Affairs, GlaxoSmithKline, Inc., Mississauga, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Lupus, SLE and health outcome

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect multiple organs in the body, including the heart, kidney and lung, leading to increasing damage over time.  Hospitalizations associated with organ damage in SLE patients across Canada have not been previously reported.  The purpose of this study was to describe trends and provincial variations in hospitalizations due to organ damage in SLE patients in Canada between 2006-2010.

Methods: Aggregate hospitalization data for most common organ manifestations (kidney, lung, pericarditis, Libman-Sacks disease) associated with SLE was obtained from the Canadian Institute for Health Information’s (CIHI) Discharge Abstract and Hospital Morbidity database, based on ICD – 10 coding, for 2006-2010. Hospitalizations associated with organ damage were reported as a function of total hospitalizations due to SLE in Canada.  Provincial data was grouped into geographical regions for ease of reporting.  Length of stay (LOS) was categorized and reported by gender and province.

Results: Overall, total count of hospitalizations due to organ damage decreased over the study period (2006: 525; 2010: 416).  Hospitalization due to kidney involvement was the most common reason for all SLE hospitalizations in Canada (2006: 48.2%; 2010: 41.7%), followed by lung involvement (2006: 9.1%; 2010: 6.8%), pericarditis (2006: 5.2%; 2010: 6.2%), Libman Sacks (2006: 0.6%; 2010: 0.5%), and other (2006: 36.9%; 2010: 44.8%). In all provinces, hospitalizations due to kidney involvement accounted for almost half of all SLE hospitalizations:  BC reported the highest rates in 2006 (52.4%), but falling by 2010 (42.7%).  A decreasing trend in SLE hospitalizations due to kidney involvement was seen in all provinces, except the Maritimes.  Hospitalizations due to lung involvement showed the highest decrease in BC between 2006 (13.5%) and 2010 (4.9%): similar decreases were seen in other provinces and Canada-wide (2006: 9.1%; 2010: 6.8%). In contrast, hospitalizations due to lupus pericarditis increased over this time period, with the highest increase recorded in BC (2006: 2.4%; 2010: 8.4%).  There was an increasing trend for patients with kidney involvement to stay longer in hospitals (12+ days; 2006: 33.2%; 2010: 35.6%), when compared to LOS due to any SLE-related hospitalizations (2006: 29%; 2010: 26.6%).  Overall, more females than males were hospitalized for organ involvement, but males LOS was longer. Limitations to the study include the possibility of double counting events due to a lack of patient level data.

Conclusion: Kidney involvement accounted for almost half of all hospitalizations related to SLE in Canada, consistent with reported higher incidences of lupus nephritis (1-3).  Overall, trends in hospitalizations tended to decrease over the time period, suggesting possibly better care of SLE patients.  However, when patients did enter hospital, they tended to stay longer, which may suggest that with current medications, disease progression continues and may lead to greater downstream costs in the Canadian health care system.


Disclosure:

A. Sayani,

GlaxoSmithKline,

1,

GlaxoSmithKline,

3;

N. Monga,

GlaxoSmithKline,

3;

M. Freeman,

GlaxoSmithKline,

1,

GlaxoSmithKline,

3;

J. Alfonso Ross Terres,

GlaxoSmithKline,

1,

GlaxoSmithKline,

3.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-hospitalizations-due-to-organ-damage-in-patients-with-systemic-lupus-erythematosus-in-canada-2006-2010/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology